Cancer Expert Witness

Untitled Document
Untitled Document

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Experience and Credentials

Graduated with honors from Harvard University and earned his medical degree from the State University of New York at Syracuse

Former Chief of Medical Oncology at MD Anderson Cancer Center-Orlando

Former Chief of Breast Medical Oncology at MD Anderson Cancer Center-Orlando

Founder and Medical Director of Cancer Center of Sarasota-Manatee

Extensive clinical trial experience with NSABP, ECOG, SWOG

Expert witness experience in State and Federal Court

Awards and Recognition

Named a "Top Physician" by Best Doctors in America for 16 consecutive years

Awarded the "People’s Physician Choice Award"

Named in the "Top Doctors" list by US News and World Report

Awarded the American College of Physicians "Excellence in Teaching Award"

Publications and Research

Mamus SW, Mladenovic J, Hordinsky MK, Dahl M and Kay NE. (1984) Cimetidine induced remission of mycosis fungoides. Lancet, II: 409.

Mamus SW, Beck-Schroeder SL and Zanjani ED. (1985) Suppression of normal human erythropoiesis by gamma interferon in vitro: role of monocytes and T lymphocytes. Journal of Clinical Investigation 75:1496-1503.

Mamus SW, Burton J, Groat JD, Schulte OA, Lobelle N and Zanjani ED. (1986) Ibuprofen associated pure white cell aplasia. New England Journal of Medicine 314:624-625.

Mamus SW, Oken MM and Zanjani ED. (1986) Cell-cell interactions erythropoiesis.Transfusion Medicine 227-244.

Mamus SW, Oken MM and Zanjani ED. (1986) Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2 interferon in vitro. Experimental Hematology14:1015-1022.

McGlave P, Mamus S, Vilen B, and DeWald G. (1987) Effect of recombinant gamma-interferon on chronic myelogenous leukemia bone marrow progenitors. Experimental Hematology 15:331-335.

Moulis H and Mamus SW. Isolated trochlear nerve palsy in a patient with Waldenstrom's macroglobulinemia: Complete recovery with combination therapy. Neurology 36: 1399.

Giles FJ, Feldman EJ, Roboz GJ, Larson RA, Mamus SW, Cortes JE, Verstovsek S, Faderal S,Talpaz M, Beran M, Albitar M, O'Brien SM, and Kantarjian HM. (2003) Phase II study of troxcitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib-resistant chronic myelogenous leukemia in blastic phase. Leukemia Research 27: 1091-1096.

Sheikholeslami MR, Ma W, Uyeji J, Tornyos K, Cone L, Mamus S, Albitar M. (2007) Bi-clonal disease in patients with chronic lymphocytic leukemia as detected by analyzing IGHV mutation-status. British Journal of Hematology 139:507-509.

Cohn AL, Myers WJ, Mamus SW, Deur C, Nicol S, Hood K, Khan MM, lIegbodu D, Asmar L. (2008) A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma.Investigational New Drugs. 26:381-386.